Daptacel Market Report 2026

Daptacel Market Overview

• The Daptacel market growth in the historic period has been driven by established childhood vaccination schedules, historical diphtheria outbreaks • Market expansion is supported by continued expansion of pediatric healthcare access, stronger disease surveillance • Growth Driver: Rising Prevalence Of Infectious Diseases And Its Impact On The Market • North America was the largest region in 2025.

What Is Covered Under Daptacel Market?

Daptacel is a DTaP vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough) in children under 7 years. It is part of the routine immunization schedule designed for children aged 6 weeks through 6 years to prevent potentially severe bacterial diseases. The main technology types of daptacel are conjugate, live, recombinant, inactivated, and toxic. Conjugate vaccines are made by linking a weak antigen to a strong antigen, which process helps the immune system respond more effectively to the weak antigen, and daptacel conjugate vaccines are commonly used to boost immunity in children against diseases. The indications include diphtheria, pertussis, and tetanus for age group types such as pediatric and adult. The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies for end users such as hospitals and clinics.

What Is The Daptacel Market Growth Forecast?

The growth in the forecast period can be attributed to continued expansion of pediatric healthcare access, stronger disease surveillance, improved vaccine delivery infrastructure, global immunization initiatives, rising parental awareness. Major trends in the forecast period include strengthening pediatric immunization programs, rising coverage of routine childhood vaccines, improved awareness of pertussis prevention, expansion of combination vaccines, government support for early life immunization.

Global Daptacel Market Segmentation

1) By Technology: Inactivated, Toxoid 2) By Indication: Diphtheria, Pertussis, Tetanus 3) By Age Group: Pediatric, Adult 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies 5) By End-Use: Hospitals, Clinics

What Are The Drivers Of The Daptacel Market?

The increasing prevalence of infectious diseases is anticipated to drive the expansion of the daptacel market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. These can spread through person-to-person contact, vectors such as insects, contaminated surfaces or food, air, bodily fluids, or direct interaction with an infected individual. The increasing prevalence of infectious diseases can be attributed to globalization, climate change, antibiotic resistance, poor sanitation, and gaps in vaccination coverage, all contributing to the faster spread and emergence of new pathogens. Daptacel, a vaccine for diphtheria, tetanus, and pertussis, helps reduce the prevalence of these infectious diseases by stimulating immune protection in individuals. Widespread vaccination significantly lowers the incidence of these diseases in communities. For instance, in August 2024, according to the UK Health Security Agency, a UK-based government department, in 2023, around 328 diphtheria cases were confirmed from 278 individuals (170 humans, 108 animals) in England, compared to 253 cases in 2022. Thus, the increasing prevalence of infectious diseases is fueling the growth of the daptacel industry. The increasing travel and mobility are expected to drive the growth of the daptacel market going forward. Advancements in transportation and the globalization of trade and business have made international travel more accessible and frequent. Additionally, the growth of tourism and cultural exchange, coupled with improved connectivity, has increased global mobility. Daptacel is essential for global travelers, protecting against diphtheria, tetanus, and pertussis and reducing the risk of disease transmission across borders. For instance, in October 2024, according to Eurostat, a Luxembourg-based provider of high-quality statistics, in 2023, the EU saw almost 2.9 billion nights spent in accommodations, with 1.6 billion by international guests compared to 2.8 billion in 2022. Notably, 15.6% of nights spent by international guests in Europe were by tourists from regions outside Europe, up from 12.6% in 2022. Therefore, the increasing global travel and mobility are propelling the growth of the daptacel industry.

Key Players In The Global Daptacel Market

Major companies operating in the daptacel market are Sanofi S.A

What Are Latest Mergers And Acquisitions In The Daptacel Market?

In November 2024, Amundi SA, a France-based asset management company that provides investment management services, acquired shares of Sanofi SA. With this acquisition, Amundi aims to strengthen its leadership in asset management and pursue responsible investment strategies through its significant acquisition of a stake in Sanofi SA. Sanofi SA is a France-based pharmaceutical industry that develops and delivers medicines and vaccines, including daptacel.

Regional Insights

North America was the largest region in the daptacel market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Daptacel Market?

The daptacel market consists of sales of single-dose vials and multi-dose vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Daptacel Market Report 2026?

The daptacel market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the daptacel industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.